Genflow Biosciences

GENF · Main Market · Health Care · mcap £12m · 1.8p

Beta Briefing, track record and bull & bear case are not ready for Genflow Biosciences yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 48 companies are already wired into a briefing: browse them.

Financials · LTM to 30 Jun 26

Source: results 29 Sep 26 ↗

Going-concern uncertainty

Revenue: –
Operating profit: −£1.1m
Net income: −£1.1m
Free cash flow: −£1.2m
Net cash: £633k
Market cap: £10.6m
EV / EBIT: –
FCF yield: −11.7%
Price / book: 55.6×

Latest half-year · H1 26 vs H1 25 results 29 Sep 26 ↗

Operating profit: −£420k
Net income: −£420k
Cash from operations: −£634k

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

Income statement Cash flow Balance sheet

Annual Half-yearly

Latest report: H1 26 (six months to 30 Jun 26), published 29 Sep 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

	LTM Jun 26	FY 25	FY 24
Gross profit	–	0.6	0.3
Operating profit	(1.1)	(1.4)	(1.6)
Profit before tax	(1.1)	(1.4)	(1.6)
Net income (owners)	(1.1)	(1.4)	(1.6)
EPS basic	(0.2p)	(0.3p)	(0.5p)
EPS diluted	(0.2p)	(0.3p)	(0.5p)

	H1 26	vs H1 25	H2 25	H1 25
Operating profit	(0.4)	n/m	(0.7)	(0.7)
Share-based payments	0.0	–	–	–
Finance costs	(0.0)	–	–	–
Profit before tax	(0.4)	n/m	(0.7)	(0.7)
Net income (owners)	(0.4)	n/m	(0.7)	(0.7)
EPS basic	(0.1p)	–	(0.1p)	(0.2p)
EPS diluted	(0.1p)	–	(0.1p)	(0.2p)

	LTM Jun 26	FY 25	FY 24
Cash from operations	(1.2)	(1.4)	(1.1)
Shares issued	1.6	1.3	0.7

	H1 26	vs H1 25	H2 25	H1 25
Cash from operations	(0.6)	n/m	(0.6)	(0.8)
Capex (PP&E)	(0.0)	–	–	–
Shares issued	1.1	+32%	0.4	0.9

	Latest Jun 26	FY 25	FY 24
Property, plant & equipment	0.0	0.0	0.0
Trade receivables	0.1	0.3	0.1
Cash	0.6	0.1	0.3
Current assets	0.7	0.5	0.4
Total assets	0.7	0.5	0.4
Trade payables	0.6	1.0	0.8
Current liabilities	0.6	1.0	–
Total liabilities	0.6	1.0	0.8
Total equity	0.2	(0.6)	(0.4)
Shares in issue	–	493.5m	–

	H1 26	H2 25	H1 25	H2 24
Property, plant & equipment	0.0	0.0	0.0	0.0
Trade receivables	0.1	0.3	0.2	0.1
Cash	0.6	0.1	0.3	0.3
Current assets	0.7	0.5	0.5	0.4
Total assets	0.7	0.5	0.5	0.4
Trade payables	0.6	1.0	0.8	0.8
Current liabilities	0.6	1.0	0.8	–
Total liabilities	0.6	1.0	0.8	0.8
Total equity	0.2	(0.6)	(0.3)	(0.4)
Shares in issue	–	493.5m	–	–

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.